Health Care

Opioid Arrest: Insys Therapeutics founder indicted

PHOENIX (AP) — U.S. prosecutors brought a fraud and racketeering case Thursday against the founder of an opioid medication maker, Insys Therapeutics (NASDAQ:INSY), that has faced increasing scrutiny from authorities across the country over allegations of pushing prescriptions of powerful painkillers amid a drug epidemic that is claiming thousands of lives each year.

Pfizer to launch consumer health sale in November -sources

Pfizer plans to kick off an auction process for its consumer healthcare business in November, paving the way for a potential $15 billion-plus sale of the headache pill to lip balm business, sources close to the matter told Reuters.

Anthem's quarterly revenue rises 21%

Anthem reported better-than-expected quarterly profit as the No. 2 U.S. health insurer added more members in its commercial and specialty business and increased its premium rates.

Chipotle turnaround stalls as food scares continued

Chipotle said Tuesday that its third-quarter profit nearly tripled and a key sales figure rose, but its adjusted earnings missed Wall Street expectations and its shares fell sharply in after-hours trading.